Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated.
The global anatomic pathology equipment and consumables market is expected to grow from $16.25 billion in 2021 to $17.86 billion in 2022 at a compound annual growth rate (CAGR) of 9.9%. The market is expected to grow to $27.09 billion in 2026 at a compound annual growth rate (CAGR) of 11%.
The anatomical pathology equipment and consumables market consist of sales of anatomical pathology equipment and consumables and related services by entities (organizations, sole traders, and partnerships) that manufacture anatomical pathology equipment and consumables to diagnose diseases. Anatomic pathology is a branch of science in which the diagnosis of the disease is carried out by examining tissues and organs at a molecular, biochemical, and microscopic level.
The main product and services in anatomical pathology are instruments, consumables, and services.The anatomical pathology instruments involved in the anatomical pathology such as the wintrobe’s tube and westergen’s tube are used as instruments for different processes in pathology.
The various applications are disease diagnosis, cancer, other diseases, and medical research. These are used by various end-users such as hospital laboratories, clinical laboratories, and others.
The rising occurrence of chronic diseases such as cancer is expected to drive the demand for the anatomic pathology equipment and consumables market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for anatomic pathology equipment and the consumables market.
The shortage of skilled professionals in clinical and diagnostic laboratories is hindering the anatomical pathology equipment and consumables market.Anatomic pathology testing requires specialized skillsets relating to life sciences, pharmaceuticals, electronics, and software.
These skillsets are available to a limited number of organizations, most of which are located in the USA and Europe.The lack of trained manpower capable of performing molecular biology experiments and interpreting the results is a major limitation in the testing and confinement of anatomic pathology equipment in developing countries.
For the few laboratory experts present in these countries, priority is given to other medical emergencies such as heart attacks and road accidents. This shortage of skilled labor is expected to be a significant deterrent to the growth of the market during the forecast period.
Companies in the anatomic pathology equipment and consumables market are increasingly investing in new technologies for better efficiency and reducing the time taken to conduct these tests.Companies such as Biogenex have developed automated staining technology such as Xmatrx and i6000 diagnostics for diverse laboratory needs.
Matrix systems offer standardized processes from baking through final glass coverslip for staining and preventing cross-contamination and i6000 diagnostics is a high-throughput system for special staining of clinical samples in molecular pathology laboratories. The i6000 diagnostics possesses a staining capacity of 200 slides in 8 hours (60 slides in 3 hours).
In June 2019, PHC Holdings Corporation acquired the anatomical pathology business of Thermo Fisher Scientific Inc for $1.14 billion. The acquired anatomical pathology business is expected to work as a new self-governing business named Epredia that will proceed to work as a leading global provider of comprehensive solutions in the anatomical pathology field, including instruments, consumables, and microscope slides.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the anatomical pathology equipment and consumables market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• May 2022
Major players in the critical illness market are China Life Insurance, Allianz, Ping An Insurance, Aviva, Legal & General, China Pacific Insurance, Prudential plc, New China Life Insurance, Aegon, and AXA. The global critical illness insurance market is expected to grow from $185.53 billion in 2021 to $215.49 billion in 2022 at a compound...
250 pages •
By The Business Research Company
• Mar 2022
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to grow from $805.47 million...
The global anti-rheumatics market reached a value of US$ 61.1 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 72.1 Billion by 2027, exhibiting at a CAGR of 2.74% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
120 pages •
By Infiniti Research Limited
• Jun 2022
Global Nasal Implants Market 2022-2026 The analyst has been monitoring the nasal implants market and it is poised to grow by $ 312.05 million during 2022-2026, accelerating at a CAGR of 5.26% during the forecast period. Our report on the nasal implants market provides a holistic analysis, market size and forecast, trends,...
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Aryl Hydrocarbon Receptor - Drugs In Development,...
The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity.This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently...
The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.